Mechanisms governing the accumulation of estrogen receptor alpha in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogens

This publication has 49 references indexed in Scilit:

• Current and future directions in medical therapy for breast carcinoma
  Cancer, 2000
• Selective estrogen receptor modulators (SERMs) in clinical practice
  Journal of the Society for Gynecologic Investigation, 2000
• Tamoxifen-Bound Estrogen Receptor (ER) Strongly Interacts with the Nuclear Matrix Protein HET/SAF-B, a Novel Inhibitor of ER-Mediated Transactivation
  Molecular Endocrinology, 2000
• Prospects for the treatment of endocrine-responsive tumours.
  Endocrine-Related Cancer, 1999
• Steroidal and nonsteroidal oestrogen antagonists in breast cancer: basic and clinical appraisal
  Trends in Pharmacological Sciences, 1998
• Interaction and Dissociation by Ligands of Estrogen Receptor and Hsp90: The Antiestrogen RU 58668 Induces a Protein Synthesis-Dependent Clustering of the Receptor in the Cytoplasm
  Molecular Endocrinology, 1998
• Tamoxifen-induced estrogen receptor up-regulation in mammary tumor cells is not related to growth inhibition
  Cancer Chemotherapy and Pharmacology, 1997
• Antiestrogenic activity of two 11β-estradiol derivatives on MCF-7 breast cancer cells
  Steroids, 1995
• Accumulation of a non-binding form of estrogen receptor in MCF-7 cells under hydroxytamoxifen treatment
  The Journal of Steroid Biochemistry and Molecular Biology, 1992
• Estrogenic and Antiestrogenic Down-regulation of Estrogen Receptor Levels: Evidence for two Different Mechanisms
  Journal of Receptor Research, 1990